Stocks›Healthcare
WatchAlert

Aptus Pharma Limited

APPL · BSE · Healthcare · As of 8 Nov 2026
₹462.05
−₹2.95 (−0.63%)(1D)
₹57.2052 Week Range₹510.90
Market Cap
₹316.97 Cr
P/E (Sector)
148.5 (32.3)
P/B Ratio
—
Dividend Yield
—
ROE
67.3%
Debt / Equity
—
Anvest Score
58/100
  • Valuation
    0
  • Quality
    100
  • Growth
    35
  • Health
    —
  • Momentum
    100
Loading company profile…

Fundamentals

P/E Ratio (TTM)
148.47
Sector median P/E
32.29
P/B Ratio
—
Sector median P/B
4.4
EPS (TTM)
₹3.11
Market Cap
₹316.97 Cr
ROE
67.35%
ROCE
104.66%
Profit Margin
9.89%
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Aptus Pharma Limited FAQs

3 topics
Expand
What does the Aptus Pharma Limited (APPL) stock page cover?
Aptus Pharma Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for APPL?
Aptus Pharma Limited is currently shown with a delayed price near ₹462.05, P/E 148.47, and ROE 67.35%.
Does the APPL page provide investment advice?
No. The APPL page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights